NCT01911715View on ClinicalTrials.gov

A Study to Explore the Routes of Elimination of MDV3100

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Healthy SubjectsPharmacokinetics of MDV3100

Interventions

DRUG

MDV3100

Oral

Trial Locations (1)

9471GP

PRA International, Zuidlaren

Sponsors

Collaborators (1)

Medivation, Inc.

All Listed Sponsors

collaborator

Medivation, Inc.

INDUSTRY

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01911715 - A Study to Explore the Routes of Elimination of MDV3100 | Biotech Hunter | Biotech Hunter